Closing the Gaps

From research labs to the halls of Congress, the Alzheimer's community has set a goal of preventing or effectively treating Alzheimer's by 2025.1 In order to attain this goal, change is needed. Together, let's take down the barriers to progress and focus our efforts on discovering a new generation of diagnostics and treatments.

What We Can Do
Increase emphasis on early detection and diagnosis of Alzheimer's disease

Many researchers believe that diagnosis and treatment in these early stages will be paramount.

Enhance public awareness and engagement

Significant public misperceptions about options for those who have been diagnosed with the disease lead to stigmatization and delayed diagnosis. Since early detection and diagnosis is critical, education about the disease and its impact is needed.

Encourage development of innovative treatments

New approaches to treating Alzheimer's disease will play a vital role in successfully preventing and effectively treating Alzheimer's. However, the path from basic research to new medicines is extremely complex with challenges along the way.

Improve the efficiency of clinical trials

A limiting factor to advancing research is the challenging process of conducting clinical trials in Alzheimer's disease research, including participant recruitment.

Develop and implement community action strategies

Cities and towns across the nation will be faced with the fiscal and societal impact of Alzheimer's disease. Implementation of the U.S. National Alzheimer's Project Act, as well as individual state and community-based plans are important to successfully preparing for this public health crisis.

1. U.S. Department of Health and Human Services. National Plan to Address Alzheimer's Disease. 2012. Available at http://alzheimers.gov/pdf/NationalPlantoAddressAlzheimersDisease.pdf. Accessed May 2016.